Copyright © 2000 by the European Society of Cardiology.
Cardiovascular risk and therapeutic benefit of coronary interventions for patients with unstable angina according to the troponin T status
a Stanford University School of Medicine, Division of Cardiovascular Medicine, California, U.S.A.
b Department of Cardiology, Hamburg University, Germany
Department of Cardiology, General Hospital Celle, Germany
Department of Cardiology, Kerckhoff-Clinic, Bad Nauheim, Germany
revised October 19, 1999; accepted October 20, 1999
Abstract
Aims Elevation of troponin T in patients with unstable angina is predictive of adverse outcomes. Since no advanced therapeutic concept for such high-risk patients has been established, we investigated cardiac risk prior to, during, and after coronary revascularization in patients with unstable angina stratified according to the troponin T status.
Methods and Results Out of 351 patients with unstable angina, troponin was elevated for 36% of the patients as determined by qualitative bedside tests. The patients were followed during hospitalization and 30 days after discharge for incidence of death and myocardial infarction. In troponin-positive patients, clinical symptoms were more refractory to medical treatment than in troponin-negative patients (78% vs 44%;P=0·002). Although these patients were catheterized earlier (1·6 vs 3·4 days;P=0·005) and more frequently (95% vs 69%;P<0·001), troponin-positive patients suffered a higher incidence of cardiac events prior to scheduled revascularization (death, myocardial infarction; 6·4% vs 0·4%;P<0·001). The angiogram for troponin-positive patients confirmed a more severe coronary artery disease requiring revascularization (69% vs 50%;P=0·001). Also the following coronary intervention was more complicated (death, myocardial infarction; 15·3% vs 4·8%;P=0·02). During the 30-day follow-up period, cardiac risk remained elevated for troponin-positive patients.
Conclusions Troponin T rapid testing reliably identified high-risk patients with unstable angina. A higher event rate was observed prior to and particularly in association with the coronary intervention. Coronary revascularization did not abrogate the increased risk of troponin-positive patients during the 30-day follow-up.
Key Words: Unstable angina, troponin T, coronary intervention, prognosis
f1 Correspondence: Dr Christopher Heeschen, Stanford University School of Medicine, Division of Cardiovascular Medicine, Stanford, CA, U.S.A.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. R. Kizer, M. R. Muttrej, W. H. Matthai, J. McConnell, H. Nardone, A. F. Sonel, M. G. Keane, and R. L. Wilensky Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention Eur. Heart J., July 2, 2003; 24(14): 1314 - 1322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Y. H. Lip and A. D. Blann Thrombogenesis and fibrinolysis in acute coronary syndromes: Important facets of a prothrombotic or hypercoagulable state? J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2044 - 2046. [Full Text] [PDF]
|
|
|
|
|
|
S.J. Brener and E.J. Topol Troponin, embolization and restoration of microvascular integrity Eur. Heart J., July 2, 2000; 21(14): 1117 - 1119. [PDF]
|
|